TAYLOR STONE: Open Payments
NPI 1508441668 · CALHOUN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 33 payments from 10 companies in 2025. Trend: 2023 $415 · 2024 $917 · 2025 $751
Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $229 |
| GENZYME CORPORATION | 5 | $151 |
| Regeneron Healthcare Solutions, Inc. | 5 | $118 |
| Lilly USA, LLC | 3 | $59 |
| UCB, Inc. | 3 | $49 |
| Botanix SB Inc | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Organon LLC | 2 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| KYOWA KIRIN, INC. | 1 | $22 |
Products named: DUPIXENT, BOTOX, SKYRIZI, TALTZ, Bimzelx, RINVOQ, SOFDRA, COSENTYX.
Industry payments across GA — which companies pay providers there.
